Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 17
132
Views
0
CrossRef citations to date
0
Altmetric
Short Communications

In vitro study of redroot pigweed effects as weed plant species on leukemia

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 4411-4414 | Received 10 Oct 2020, Accepted 11 Sep 2021, Published online: 31 Dec 2021
 

Abstract

Redroot pigweed is a well-known allelopathic weed worldwide with diverse organic compounds which involving in its allelopathic interactions as well. Preliminary tests of redroot pigweed extract against leukemia and various human phatogenic microorganisms revealed that amaranth extract inhibits the viability and proliferation of NB4 cells in a time- and dose-dependent manner and has an excellent anti-bacterial effect on gram-positive bacteria and Candida fungi. Interestingly, the anti-luekemia effects of redroot pigweed is reported for the first time. Phytochemical analysis of redroot pigweed extract, led to the identification amaranth bioactive compounds that largely were including terpenoid compounds (51.71%) as the main group and Carvacrol (11.33%) was the key compound. Redroot pigweed contains various organic compounds with allelopathic and therapeutic properties and current investigation is a promising revelation for the pharmaceutical importance of this plant.

Graphical Abstract

Acknowledgements

The authors are grateful to the Research Affairs of the University of Tabriz for financial and other supports. We also thankful to Mr. Amirhosein Talebpour for collection of plant samples.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.